EUR 234.5
(0.51%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 2.28 Billion EUR | 6.37% |
2022 | 2.15 Billion EUR | 48.62% |
2021 | 1.44 Billion EUR | 1603.53% |
2020 | 85 Million EUR | -92.11% |
2019 | 1.07 Billion EUR | -0.55% |
2018 | 1.08 Billion EUR | 37.26% |
2017 | 789 Million EUR | -2.95% |
2016 | 813 Million EUR | 7.4% |
2015 | 757 Million EUR | -18.51% |
2014 | 929 Million EUR | 56.66% |
2013 | 593 Million EUR | 1.54% |
2012 | 584 Million EUR | 15.5% |
2011 | 505.61 Million EUR | 9.45% |
2010 | 461.96 Million EUR | 18.25% |
2009 | 390.68 Million EUR | 2.18% |
2008 | 382.35 Million EUR | 4.26% |
2007 | 366.74 Million EUR | 11.56% |
2006 | 328.73 Million EUR | 14.18% |
2005 | 287.91 Million EUR | 17.79% |
2004 | 244.42 Million EUR | 8.13% |
2003 | 226.05 Million EUR | 13.34% |
2002 | 199.44 Million EUR | 21.55% |
2001 | 164.07 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 1.36 Billion EUR | 0.0% |
2023 Q2 | 1.36 Billion EUR | 0.0% |
2023 Q4 | 928 Million EUR | 0.0% |
2023 FY | 2.28 Billion EUR | 6.37% |
2022 Q4 | 979 Million EUR | 0.0% |
2022 FY | 2.15 Billion EUR | 48.62% |
2022 Q2 | 1.17 Billion EUR | 0.0% |
2021 Q2 | 854 Million EUR | 0.0% |
2021 Q4 | 609 Million EUR | 0.0% |
2021 FY | 1.44 Billion EUR | 1603.53% |
2020 Q4 | 497 Million EUR | 0.0% |
2020 Q2 | -412 Million EUR | 0.0% |
2020 FY | 85 Million EUR | -92.11% |
2019 Q4 | 402 Million EUR | 0.0% |
2019 Q2 | 675 Million EUR | 0.0% |
2019 FY | 1.07 Billion EUR | -0.55% |
2018 Q4 | 553 Million EUR | 0.0% |
2018 FY | 1.08 Billion EUR | 37.26% |
2018 Q2 | 530 Million EUR | 0.0% |
2017 FY | 789 Million EUR | -2.95% |
2017 Q2 | 389 Million EUR | 0.0% |
2017 Q4 | 651 Million EUR | 0.0% |
2016 FY | 813 Million EUR | 7.4% |
2016 Q2 | 416 Million EUR | 0.0% |
2016 Q4 | 397 Million EUR | 0.0% |
2015 Q2 | 388 Million EUR | 0.0% |
2015 FY | 757 Million EUR | -18.51% |
2015 Q4 | 369 Million EUR | 0.0% |
2014 Q2 | 699 Million EUR | 0.0% |
2014 FY | 929 Million EUR | 56.66% |
2014 Q4 | 230 Million EUR | 0.0% |
2013 Q2 | 310 Million EUR | 0.0% |
2013 FY | 593 Million EUR | 1.54% |
2013 Q4 | 283 Million EUR | 0.0% |
2012 Q4 | 157.6 Million EUR | 0.0% |
2012 Q2 | 157.6 Million EUR | 0.0% |
2012 Q1 | 157.6 Million EUR | 21.66% |
2012 FY | 584 Million EUR | 15.5% |
2012 Q3 | 157.6 Million EUR | 0.0% |
2011 Q2 | 129.54 Million EUR | 0.0% |
2011 Q3 | 129.54 Million EUR | 0.0% |
2011 Q4 | 129.54 Million EUR | 0.0% |
2011 FY | 505.61 Million EUR | 9.45% |
2011 Q1 | 129.54 Million EUR | 9.78% |
2010 Q3 | 118 Million EUR | 0.0% |
2010 FY | 461.96 Million EUR | 18.25% |
2010 Q4 | 118 Million EUR | 0.0% |
2010 Q2 | 118 Million EUR | 0.0% |
2010 Q1 | 118 Million EUR | 17.46% |
2009 Q1 | 100.46 Million EUR | 10.78% |
2009 Q2 | 100.46 Million EUR | 0.0% |
2009 Q3 | 100.46 Million EUR | 0.0% |
2009 Q4 | 100.46 Million EUR | 0.0% |
2009 FY | 390.68 Million EUR | 2.18% |
2008 Q3 | 90.68 Million EUR | 0.0% |
2008 Q2 | 90.68 Million EUR | 0.0% |
2008 Q1 | 90.68 Million EUR | 6.03% |
2008 FY | 382.35 Million EUR | 4.26% |
2008 Q4 | 90.68 Million EUR | 0.0% |
2007 FY | 366.74 Million EUR | 11.56% |
2007 Q4 | 85.53 Million EUR | 0.0% |
2007 Q3 | 85.53 Million EUR | 0.0% |
2007 Q2 | 85.53 Million EUR | 0.0% |
2007 Q1 | 85.53 Million EUR | 13.04% |
2006 Q1 | 75.66 Million EUR | 13.52% |
2006 Q4 | 75.66 Million EUR | 0.0% |
2006 Q3 | 75.66 Million EUR | 0.0% |
2006 Q2 | 75.66 Million EUR | 0.0% |
2006 FY | 328.73 Million EUR | 14.18% |
2005 Q4 | 66.65 Million EUR | 0.0% |
2005 Q2 | 66.65 Million EUR | 0.0% |
2005 FY | 287.91 Million EUR | 17.79% |
2005 Q1 | 66.65 Million EUR | -42.68% |
2005 Q3 | 66.65 Million EUR | 0.0% |
2004 FY | 244.42 Million EUR | 8.13% |
2004 Q3 | 116.28 Million EUR | 0.0% |
2004 Q1 | 116.28 Million EUR | 105.77% |
2004 Q2 | 116.28 Million EUR | 0.0% |
2004 Q4 | 116.28 Million EUR | 0.0% |
2003 Q1 | 56.51 Million EUR | -36.5% |
2003 Q4 | 56.51 Million EUR | 0.0% |
2003 FY | 226.05 Million EUR | 13.34% |
2003 Q3 | 56.51 Million EUR | 0.0% |
2003 Q2 | 56.51 Million EUR | 0.0% |
2002 Q3 | 89 Million EUR | 0.0% |
2002 FY | 199.44 Million EUR | 21.55% |
2002 Q2 | 89 Million EUR | 0.0% |
2002 Q1 | 89 Million EUR | 116.98% |
2002 Q4 | 89 Million EUR | 0.0% |
2001 FY | 164.07 Million EUR | 0.0% |
2001 Q3 | 41.01 Million EUR | 0.0% |
2001 Q2 | 41.01 Million EUR | 0.0% |
2001 Q1 | 41.01 Million EUR | 0.0% |
2001 Q4 | 41.01 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Crossject Société Anonyme | -8.63 Million EUR | 26599.19% |
Safe Orthopaedics SA | -6.96 Million EUR | 32964.322% |
Spineway SA | -6.51 Million EUR | 35261.29% |
Amplitude Surgical SA | 1.5 Million EUR | -152500.0% |
Sartorius Stedim Biotech S.A. | 309.7 Million EUR | -639.102% |
bonyf N.V. | -1.04 Million EUR | 219204.835% |